TORINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 22.487
AS - Asia 3.481
EU - Europa 2.953
SA - Sud America 479
AF - Africa 69
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 7
Totale 29.506
Nazione #
US - Stati Uniti d'America 22.358
SG - Singapore 1.511
IT - Italia 886
CN - Cina 678
BR - Brasile 396
HK - Hong Kong 363
RU - Federazione Russa 359
VN - Vietnam 346
DE - Germania 320
UA - Ucraina 306
IE - Irlanda 226
FI - Finlandia 189
FR - Francia 171
GB - Regno Unito 154
JP - Giappone 129
NL - Olanda 89
CA - Canada 84
KR - Corea 80
IN - India 67
ID - Indonesia 57
SE - Svezia 53
TR - Turchia 50
PL - Polonia 32
AR - Argentina 31
BD - Bangladesh 29
AT - Austria 28
AU - Australia 27
MX - Messico 27
CZ - Repubblica Ceca 26
BE - Belgio 25
TW - Taiwan 24
IR - Iran 19
ZA - Sudafrica 17
ES - Italia 16
EC - Ecuador 15
GR - Grecia 13
IQ - Iraq 13
MY - Malesia 13
NP - Nepal 13
PK - Pakistan 13
SA - Arabia Saudita 13
AL - Albania 12
CO - Colombia 12
PH - Filippine 12
CL - Cile 11
CH - Svizzera 10
EG - Egitto 10
TH - Thailandia 10
MA - Marocco 9
TN - Tunisia 9
LT - Lituania 7
RO - Romania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
EU - Europa 6
PT - Portogallo 6
UZ - Uzbekistan 6
DK - Danimarca 5
JM - Giamaica 5
NO - Norvegia 5
PY - Paraguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
NG - Nigeria 4
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PE - Perù 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
KH - Cambogia 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
PG - Papua Nuova Guinea 1
QA - Qatar 1
Totale 29.503
Città #
Woodbridge 5.943
Houston 5.080
Wilmington 5.040
Singapore 936
Fairfield 622
Chandler 592
Ashburn 500
Ann Arbor 447
San Jose 366
Hong Kong 346
Beijing 316
Council Bluffs 264
Rome 262
Seattle 261
Jacksonville 249
Dublin 215
Cambridge 205
The Dalles 181
New York 155
Medford 153
Helsinki 115
Santa Clara 111
Dearborn 102
Los Angeles 98
Tokyo 93
Hanoi 86
Lawrence 75
Milan 74
Buffalo 73
Ho Chi Minh City 72
Dallas 69
Lauterbourg 62
Moscow 62
Redwood City 55
Chicago 54
Boardman 53
Jakarta 43
Munich 43
San Diego 42
Dong Ket 39
São Paulo 39
Phoenix 34
London 31
Menlo Park 29
Mülheim 27
Nuremberg 27
North Bergen 25
Salt Lake City 25
Columbus 23
Montreal 23
Nanjing 22
Warsaw 22
Brno 21
Brussels 21
Amsterdam 20
Brooklyn 20
Sanayi 18
Orem 17
Redondo Beach 17
Toronto 17
Denver 16
Escondido 16
Lachine 16
New Kensington 16
Norwalk 16
University Park 16
Naples 15
Taipei 14
Guangzhou 13
Poplar 13
Verona 13
Vienna 13
Falls Church 12
Florence 12
Frankfurt am Main 12
Lappeenranta 12
Rio de Janeiro 12
Shanghai 12
Stockholm 12
Zhengzhou 12
Istanbul 11
Johannesburg 11
Mountain View 11
Tampa 11
Belo Horizonte 10
Da Nang 10
Hefei 10
Kathmandu 10
Manchester 10
Turin 10
Boston 9
Chennai 9
Curitiba 9
Sydney 9
Engelhard 8
Haiphong 8
Kunming 8
Miami 8
Palermo 8
Ankara 7
Totale 24.492
Nome #
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES) 611
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. 586
La mutualità nel caregiving: una revisione della letteratura 572
Prometheus: A Project for the Dissemination of Knowledge within the Oncology Network of Piedmont and Aosta Valley. 539
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 530
Focus on Fotemustine 491
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 488
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. 488
Thyroid dysfunction as an unintended side effect of anticancer drugs. 488
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. 483
Circulating tumor cells in colorectal cancer patients 483
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 476
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 469
A rare case of juvenile hypertension: Coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism 465
Medullary thyroid cancer: a promising model for targeted therapy. 463
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 457
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. 455
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 454
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives. 453
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 452
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. 451
Endocrine side effects induced by immune checkpoint inhibitors. 450
Endocrinological side-effects of immune checkpoint inhibitors 442
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer. 440
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model 440
Endocrine side effects induced by immune checkpoint inhibitors. 438
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 434
Mouse models of medullary thyroid cancer and developing new targeted therapies 430
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? 429
Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. 429
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 428
Targeted therapy of breast cancer. 426
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. 424
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. 423
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 420
Therapy of breast cancer with molecular targeting agents. 417
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. 417
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. 416
Skin acrometastases in squamous cell carcinoma of the tongue. 412
Therapeutic agents that inhibit angiogenesis. 412
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 410
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. 405
Genetic and molecular pathophysiology of medullary thyroid cancer. 401
Clinical utility of lanreotide autogel® in gastroenteropancreatic neuroendocrine tumors 393
Is tailored therapy feasible in oncology? 392
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram 392
Tailored therapy of colorectal cancer: results, challenges and future directions. 389
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 386
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? 378
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES). 377
Barriers in the management of cancerrelated pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy 371
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 366
Combination of antiangiogenic therapy with other anticancer treatment. 361
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. 358
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 356
Molecular targeted therapy of medullary thyroid carcinoma 332
Gut microbiota and cancer: From pathogenesis to therapy 234
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 223
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art 207
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 173
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 162
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms 158
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? 144
Development and content validity of the self-care of oral anticancer agents index 142
Validity and Reliability of the Self-Care of Chronic Illness Inventory and Self-Care Self-Efficacy Scale in Patients Living With Cancer 140
Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer 135
Apoptosis as a Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer 131
A systematic review of self-care behaviours among patients with cancer who take oral anticancer agents 127
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 122
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 121
Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review 120
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study 115
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 114
Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review 114
Describing self-care behaviours in cancer patients taking oral anticancer agents 113
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention 113
La Terza Missione dell'Università: formazione e salute 112
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review 112
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI) 110
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 107
Psychometric Properties of the Self Care Oral Anticancer Agents Index (SCOAAI) 102
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy 97
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition 86
Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy 86
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 85
Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review 83
Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study 83
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 82
CN29 Short term effects of self-care behaviours on quality of life for patients on oral anticancer agents 81
Predictors of self-care in patients with cancer treated with oral anticancer agents: A systematic review 80
Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study 79
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 78
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 78
AMBRA1 and SQSTM1 expression pattern in prostate cancer 77
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma 74
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis 74
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 73
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 73
Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case Report 61
Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature 59
Totale 29.488
Categoria #
all - tutte 72.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021400 0 0 0 0 0 0 0 0 0 162 145 93
2021/2022922 44 74 41 50 35 71 47 43 53 109 64 291
2022/20231.438 137 154 130 158 107 267 82 93 116 23 125 46
2023/2024621 85 34 32 27 48 106 37 32 22 17 16 165
2024/20252.583 87 474 200 135 76 178 222 176 222 344 258 211
2025/20264.578 425 208 474 337 512 201 784 618 545 474 0 0
Totale 29.789